Skip to content
Search

Latest Stories

Wolverhampton pharmacist sentenced for Covid-19 grant fraud

The Pharmacist submitted eight grant applications containing “fake quotations” to the Relight Programme, seeking a total of £40,000 in funding.

Wolverhampton pharmacist Sundip Gill convicted for Covid-19 grant fraud

Pharmacist jailed for submitting “fake quotations” in Covid-19 grant applications

gettyimages

Sundip Gill, a registered pharmacist from Wolverhampton, has been sentenced to imprisonment after being found guilty of fraud related to Covid-19 grant applications.

According to the City of Wolverhampton Council, Gill made “false representations” and supplied “fake quotations” to support funding applications.


Gill is the director of two pharmaceutical companies, Sync Chem Ltd and Collateral Ltd, and operates four pharmacy businesses in Wolverhampton—Collateral, Your Pharmacy First, Low Hill Pharmacy, and Fallings Park Pharmacy.

During the Covid-19 pandemic, the government introduced grants to support local businesses.

As part of this initiative, the City of Wolverhampton Council launched the Relight Programme and allocated extra funding to help businesses improve their premises and increase carbon efficiency.

Businesses could apply for two grants and, if they met the qualifying criteria, could receive up to £5,000 for each successful application.

According to the council, Gill submitted eight grant applications to the programme and had the potential to receive a total of £40,000.

However, the council’s Counter Fraud Team were alerted to “discrepancies with the quotations” supplied by Gill.”

Upon investigations, it was discovered that Gill had submitted “fake quotations in support of his grant applications,” the council said.

“Following a detailed investigation, Gill was charged with 18 offences of dishonesty and Sync Chem Ltd and Collateral Ltd were charged with six offences of dishonesty, all under sections 1, 2 and 7 of the Fraud Act 2006,” it stated.

Gill denied the charges but was subsequently found guilty on all counts at Dudley Magistrates Court on 21 February.

He was sentenced to 20 weeks imprisonment, suspended for 12 months, ordered to complete 200 hours of unpaid work within a year. Additionally, he was ordered to pay £3,000 in costs and a £128 victim surcharge.

His two companies, Sync Chem Ltd and Collateral Ltd, were fined £14,690 and £8,690 respectively.

“You have been convicted for being fully involved in fraud and your attempts to exploit a system to assist legitimate businesses,” district judge Graham Wilkinson told Gill during sentencing.

He added that Gill had shown “no remorse.”

Councillor Louise Miles, cabinet member for resources at the City of Wolverhampton Council, condemned the abuse of the scheme, stating: “The Relight Programme was designed to support local business through, and to recover from, the Covid-19 pandemic, and not to be abused in the way that it was by Sundip Gill.”

She reaffirmed the council’s “zero tolerance” policy towards public sector fraud.

“It is far from a victimless crime, and its impacts ripple through our society, affecting every individual and the services we all rely on, and we will not hesitate to take action in instances like this,” she added.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less